Severe injection site reactions after subcutaneous administration of Sayana®: a retrospective, post-marketing analysis of WHO and Swiss spontaneous pharmacovigilance reports. (2017). Swiss Medical Weekly, 147(1920), w14432. https://doi.org/10.4414/smw.2017.14432